Health Crisis Deepens in England's NHS Hospitals
Thousands Receive Corridor Care as Scientists Seek Solutions to Aging and Gut Health
Read latest briefing →⚕️ Desk
Health, Medicine, Wellness and healthcare developments
Thousands Receive Corridor Care as Scientists Seek Solutions to Aging and Gut Health
Read latest briefing →Desk archive
From taboo subjects to medical research controversies, women's health is in the spotlight
Hospitals adapt to doctor strikes, Ebola response requires community engagement, and global blood donations see significant increase.
Recent developments in healthcare, from pain relief for period cramps to global health concerns
Promising results from AstraZeneca and Lilly, plus a new solution for "Ozempic butt
Exploring breakthroughs in medical research and their implications for public health
Patients face cancelled appointments and delayed treatments as doctors demand better pay
A round-up of recent stories on family bonding, pharmaceutical breakthroughs, and medical staffing challenges
Doctors' strike looms, patient care falls short, and period poverty persists
Recent Developments in Cancer Research, Obesity Diagnosis, and Heat-Related Deaths
From community-led mental health initiatives to FDA breakthroughs and tariff negotiations
Advances in AR tech, HIV prevention, and endometriosis treatment face budget cuts and regulatory hurdles
FDA delays, doctor strikes, and AI advancements raise concerns and opportunities in the healthcare sector
Breakthroughs in bone health, hepatitis E treatment, and global collaboration offer new hope
Doctors' strikes, insurance woes, and medical discoveries impact patients nationwide
Inquiry report praises vaccine rollout, while bird flu vaccine trials start
New vaccine breakthroughs, hospital innovations, and concerns over doctor pay and social media's impact on wellbeing
The UK has seen a surge in health-related news, from the rollout of free meningitis B vaccines for young people to the devastating impact of the recent heatwaves.
Bayer sues J&J over claims that its prostate cancer treatment is more effective, citing flawed data and false advertising; lawsuit seeks damages and corrective action.
New pathway expected to spur applications for rare disease treatments
Setbacks for lung disease, puberty blockers, and cancer blood test studies
Scientists develop a simple test to predict onset of memory loss
Gilead Sciences is buying Arcellx for $7.8 billion, expanding its CAR-T therapy portfolio, while Novo Nordisk's next-gen obesity drug underperformed in a comparison study.
As the midterms approach, health care is in the spotlight, with lobbyists targeting the FDA, AI devices potentially bypassing review, and reform efforts facing an uphill battle.